The effects of apoptosis vulnerability markers on the myocardium in depression after myocardial infarction

BMC Medicine

Volumn 11, Issue 1, 2013, Pages

  Wang, Yiming ^a,b   Liu, Xingde ^a   Zhang, Dongfeng ^a,c   Chen, Jianhui ^a   Liu, Shuzheng ^a   Berk, Michael ^b,d,e  

^a GUIZHOU MEDICAL UNIVERSITY   (China)

^b DEAKIN UNIVERSITY   (Australia)

^c Rehabilitation Department   (China)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

apoptosis; cardiac; comorbidity.; major depressive disorder; myocardial infarction; myocardium; stress

Indexed keywords

CASPASE 3; MESSENGER RNA; PROTEIN BAX; PROTEIN BCL 2; SUCROSE; TRIPHENYLTETRAZOLIUM;

ANHEDONIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BEHAVIOR DISORDER; CARDIOVASCULAR RISK; CHRONIC STRESS; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; GENE EXPRESSION; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE; HEART MUSCLE; MALE; NONHUMAN; OPEN FIELD TEST; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SHAM PROCEDURE; UPREGULATION;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; DEPRESSION; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; IMMUNOHISTOCHEMISTRY; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84873451263     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-11-32     Document Type: Article

References (48)

1. Charlson FJ, Stapelberg NJ, Baxter AJ, Whiteford HA. Should global burden of disease estimates include depression as a risk factor for coronary heart disease?. BMC Med 2011, 9:1-6. 10.1186/1741-7015-9-1, 3025873, 21219637.
2. Ikenouchi-Sugita A, Yoshimura R, Kishi T, Umene-Nakano W, Hori H, Hayashi K, Katsuki A, Ueda N, Iwata N, Nakamura J. Three polymorphisms of the eNOS gene and plasma levels of metabolites of nitric oxide in depressed Japanese patients: a preliminary report. Hum Psychopharmacol 2011, 26:531-534. 10.1002/hup.1239, 22031268.
3. May HT, Horne BD, Carlquist JF, Sheng X, Joy E, Catinella AP. Depression after coronary artery disease is associated with heart failure. J Am Coll Cardiol 2009, 53:1440-1447. 10.1016/j.jacc.2009.01.036, 19371828.
4. Spertus JA, McDonell M, Woodman CL, Fihn SD. Association between depression and worse disease-specific functional status in outpatients with coronary artery disease. Am Heart J 2000, 140:105-110. 10.1067/mhj.2000.106600, 10874270.
5. Pignay-Demaria V, Lespérance F, Demaria FG, Frasure-Smith N, Perrault LP. Depression and anxiety and outcomes of coronary artery bypass surgery. Ann Thorac Surg 2003, 75:314-321. 10.1016/S0003-4975(02)04391-6, 12537248.
6. Thom T, Haase N, Rosamond W, Howard VJ, Rumsfeld J, Manolio T, Zheng ZJ, Flegal K, O'Donnell C, Kittner S, Lloyd-Jones D, Goff DC, Hong Y, Adams R, Friday G, Furie K, Gorelick P, Kissela B, Marler J, Meigs J, Roger V, Sidney S, Sorlie P, Steinberger J, Wasserthiel-Smoller S, Wilson M, Wolf P. Heart disease and stroke statistics-2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006, 113:e85-151. 10.1161/CIRCULATIONAHA.105.171600, 16407573.
7. Strik JJ, Honig A, Maes M. Depression and myocardial infarction: relationship between heart and mind. Prog Neuropsychopharmacol Biol Psychiatry 2001, 25:879-892. 10.1016/S0278-5846(01)00150-6, 11383983.
8. von Känel R, Begré S. Depression after myocardial infarction: unraveling the mystery of poor cardiovascular prognosis and role of beta-blocker therapy. J Am Coll Cardiol 2006, 48:2215-2217. 10.1016/j.jacc.2006.09.007, 17161248.
9. van Melle JP, de Jonge P, Spijkerman TA, Tijssen JG, Ormel J, van Veldhuisen DJ, van den Brink RH, van den Berg MP. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom Med 2004, 66:814-822. 10.1097/01.psy.0000146294.82810.9c, 15564344.
10. Carney RM, Freedland KE. Depression, mortality, and medical morbidity in patients with coronary heart disease. Biol Psychiatry 2003, 54:241-247. 10.1016/S0006-3223(03)00111-2, 12893100.
11. Fauerbach JA, Bush DE, Thombs BD, McCann UD, Fogel J, Ziegelstein RC. Depression following acute myocardial infarction: a prospective relationship with ongoing health and function. Psychosomatics 2005, 46:355-361. 10.1176/appi.psy.46.4.355, 16000679.
12. Nuñez G, Clarke MF. The Bcl-2 family of proteins: regulators of cell death and survival. Trends Cell Biol 1994, 4:399-403. 10.1016/0962-8924(94)90053-1, 14731816.
13. White E. Life, death and the pursuit of apoptosis. Genes Dev 1996, 10:1-15. 10.1101/gad.10.1.1, 8557188.
14. Vekrellis K, McCarthy MJ, Watson A, Whitfield J, Rubin LL, Ham J. Bax promotes neuronal cell death and is downregulated during the development of the nervous system. Development 1997, 124:1239-1249.
15. Cory S, Huang DC, Adams JM. The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene 2003, 22:8590-8607. 10.1038/sj.onc.1207102, 14634621.
16. Jarskog LF, Selinger ES, Lieberman JA, Gilmore JH. Apoptotic proteins in the temporal cortex in schizophrenia: high bax/bcl-2 ratio without caspase-3 activation. Am J Psychiatry 2004, 161:109-115. 10.1176/appi.ajp.161.1.109, 14702258.
17. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993, 74:609-619. 10.1016/0092-8674(93)90509-O, 8358790.
18. Wann BP, Bah TM, Kaloustian S, Boucher M, Dufort AM, Le Marec N, Godbout R, Rousseau G. Behavioural signs of depression and apoptosis in the limbic system following myocardial infarction: effects of sertraline. J Psychopharmacol 2009, 23:451-459. 10.1177/0269881108089820, 18562428.
19. Fan TJ, Han LH, Cong RS, Liang J. Caspase family proteases and apoptosis. Acta Biochim Biophys Sin 2005, 37:719-727. 10.1111/j.1745-7270.2005.00108.x, 16270150.
20. Boucher M, Wann BP, Kaloustian S, Massé R, Schampaert E, Cardinal R, Rousseau G. Sustained cardioprotection afforded by A2A adenosine receptor stimulation after 72 hours of myocardial reperfusion. J Cardiovasc Pharmacol 2005, 45:439-446. 10.1097/01.fjc.0000159047.73359.08, 15821439.
21. Wann BP, Boucher M, Kaloustian S, Nim S, Godbout R, Rousseau G. Apoptosis detected in the amygdala following myocardial infarction in the rat. Biol Psychiatry 2006, 59:430-433. 10.1016/j.biopsych.2005.07.018, 16202395.
22. Girard SA, Bah TM, Kaloustian S, Lada-Moldovan L, Rondeau I, Tompkins TA, Godbout R, Rousseau G. Lactobacillus helveticus and Bifidobacterium longum taken in combination reduce the apoptosis propensity in the limbic system after myocardial infarction in a rat model. Br J Nutr 2009, 102:1420-1425. 10.1017/S0007114509990766, 19563693.
23. Wann BP, Bah TM, Boucher M, Courtemanche J, Le Marec N, Rousseau G, Godbout R. Vulnerability for apoptosis in the limbic system after myocardial infarction in rats: a possible model for human postinfarct major depression. J Psychiatry Neurosci 2007, 32:11-16. 1764546, 17245469.
24. Wang Y, Xiao Z, Liu X, Berk M. Venlafaxine modulates depression-induced behaviour and the expression of Bax mRNA and Bcl-xl mRNA in both hippocampus and myocardium. Hum Psychopharmacol 2011, 26:95-101. 10.1002/hup.1177, 21308783.
25. Willner P, Muscat R, Papp M. Chronic mild stress-induced anhedonia: a realistic animal model of depression. Neurosci Biobehav Rev 1992, 16:525-534. 10.1016/S0149-7634(05)80194-0, 1480349.
26. Wu JC, Chen IY, Wang Y, Tseng JR, Chhabra A, Salek M, Min JJ, Fishbein MC, Crystal R, Gambhir SS. Molecular imaging of the kinetics of vascular endothelial growth factor gene expression in ischemic myocardium. Circulation 2004, 110:685-691. 10.1161/01.CIR.0000138153.02213.22, 15302807.
27. Wehrens XH, Kirchhoff S, Doevendans PA. Mouse electrocardiography: an interval of thirty years. Cardiovasc Res 2000, 45:231-237. 10.1016/S0008-6363(99)00335-1, 10728340.
28. Moreau JL, Jenck F, Martin JR, Mortas P, Haefely WE. Antidepressant treatment prevents chronic unpredictable mild stress-induced anhedonia as assessed by ventral tegmentum self-stimulation behavior in rats. Eur Neuropsychopharmacol 1992, 2:43-49. 10.1016/0924-977X(92)90035-7, 1638173.
29. Willner P, Towell A, Sampson D, Sophokleous S, Muscat R. Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology 1987, 93:358-364.
30. Montgomery KS, Mackey J, Thuett K, Ginestra S, Bizon JL, Abbott LC. Chronic, low-dose prenatal exposure to methylmercury impairs motor and mnemonic function in adult C57/B6 mice. Behav Brain Res 2008, 191:55-61. 10.1016/j.bbr.2008.03.008, 18436314.
31. Grippo AJ, Beltz TG, Weiss RM, Johnson AK. The effects of chronic fluoxetine treatment on chronic mild stress-induced cardiovascular changes and anhedonia. Biol Psychiatry 2006, 59:309-316. 10.1016/j.biopsych.2005.07.010, 16154542.
32. Katz RJ, Roth KA, Carroll BJ. Acute and chronic stress effects on open field activity in the rat: implications for a model of depression. Neurosci Biobehav Rev 1981, 5:247-251. 10.1016/0149-7634(81)90005-1, 7196554.
33. Erdodan F, Golgeli A, Arman F, Ersoy AO. The effects of pentylenetetrazole induced status epilepticus on behavior, emotional memory and learning in rats. Epilepsy Behav 2004, 5:388-393. 10.1016/j.yebeh.2004.03.001, 15145309.
34. Henningsen K, Andreasen JT, Bouzinova EV, Jayatissa MN, Jensen MS, Redrobe JP, Wiborg O. Cognitive deficits in the rat chronic mild stress model for depression: relation to anhedonic-like responses. Behav Brain Res 2009, 198:136-141. 10.1016/j.bbr.2008.10.039, 19038290.
35. Zhang H, Liu L, Huang G, Zhou L, Wu W, Zhang T, Huang H. Protective effect of electroacupuncture at the Neiguan point in a rabbit model of myocardial ischemia-reperfusion injury. Can J Cardiol 2009, 25:359-563. 10.1016/S0828-282X(09)70095-9, 2722479, 19536377.
36. McConnell S, Jacka FN, Williams LJ, Dodd S, Berk M. The relationship between depression and cardiovascular disease. Int J Psychiatry Clin Pract 2005, 9:157-167.
37. Ho YL, Chen CL, Hsu RB, Lin LC, Huang PJ. The correlation between expression of apoptosis-related proteins and myocardial functional reserve evaluated by dobutamine stress echocardiography in patients with dilated cardiomyopathy. J Am Soc Echocardiogr 2003, 16:931-936. 10.1016/S0894-7317(03)00424-3, 12931104.
38. van Empel VP, Bertrand AT, Hofstra L, Crijns HJ, Doevendans PA, De Windt LJ. Myocyte apoptosis in heart failure. Cardiovasc Res 2005, 67:21-29. 10.1016/j.cardiores.2005.04.012, 15896727.
39. Pasco JA, Nicholson GC, Ng F, Henry MJ, Williams LJ, Kotowicz MA, Hodge JM, Dodd S, Kaczynski F, Gama CS, Berk M. Oxidative stress may be a common mechanism linking major depression and osteoporosis. Acta Neuropsychiatrica 2008, 20:112-116.
40. Kurisu S, Sato H, Kawagoe T, Ishihara M, Shimatani Y, Nishioka K, Kono Y, Umemura T, Nakamura S. Tako-tsubo-like left ventricular dysfunction with ST-segment elevation: a novel cardiac syndrome mimicking acute myocardial infarction. Am Heart J 2002, 143:448-455. 10.1067/mhj.2002.120403, 11868050.
41. Moylan S, Maes M, Wray NR, Berk M. The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications. Mol Psychiatry 2012,
42. Salakou S, Kardamakis D, Tsamandas AC, Zolota V, Apostolakis E, Tzelepi V, Papathanasopoulos P, Bonikos DS, Papapetropoulos T, Petsas T, Dougenis D. Increased Bax/Bcl-2 ratio up-regulates caspase-3 and increases apoptosis in the thymus of patients with myasthenia gravis. In Vivo 2007, 21:123-132.
43. Leri A, Claudio PP, Li Q, Wang X, Reiss K, Wang S, Malhotra A, Kajstura J, Anversa P. Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell. J Clin Invest 1998, 101:1326-1342. 10.1172/JCI316, 508710, 9525975.
44. Wernig F, Xu Q. Mechanical stress-induced apoptosis in the cardiovascular system. Prog Biophys Mol Biol 2002, 78:105-137. 10.1016/S0079-6107(02)00008-1, 12429110.
45. Lancel S, Joulin O, Favory R, Goossens JF, Kluza J, Chopin C, Formstecher P, Marchetti P, Neviere R. Ventricular myocyte caspases are directly responsible for endotoxin-induced cardiac dysfunction. Circulation 2005, 111:2596-2604. 10.1161/CIRCULATIONAHA.104.490979, 15897345.
46. Frantz S, Ducharme A, Sawyer D, Rohde LE, Kobzik L, Fukazawa R, Tracey D, Allen H, Lee RT, Kelly RA. Targeted deletion of caspase-1 reduces early mortality and left ventricular dilatation following myocardial infarction. J Mol Cell Cardiol 2003, 35:685-694. 10.1016/S0022-2828(03)00113-5, 12788386.
47. Pasco JA, Kotowicz MA, Henry MJ, Nicholson GC, Spilsbury HJ, Box JD, Schneider HG. High-sensitivity C-reactive protein and fracture risk in elderly women. JAMA 2006, 296:1353-1355. 10.1001/jama.296.11.1353, 16985226.
48. Maes M, Ruckoanich P, Chang YS, Mahanonda N, Berk M. Multiple aberrations in shared inflammatory and oxidative & nitrosative stress (IO&NS) pathways explain the co-association of depression and cardiovascular disorder (CVD), and the increased risk for CVD and due mortality in depressed patients. Prog Neuropsychophrmacol Biol Psychiatry 2011, 35:769-783.